Search
London Partnering Day Flyer -Update V5 2018 04 18.pdf
London Partnering Day Flyer -Update V5 2018 04 18.pdf
Partnering Day France Flyer Save the date 2018 08 02.pdf
CNS_Partnering_Interests-2018-12.pdf
Grass_Roots_Partnering_Initiatives.pdf
CardioMetabolic_Partnering_Interests_2018-12.pdf
CNS_Partnering-2019-01.pdf
Immunology_Partnering_Interests_2018-12.pdf
Oncology_Partnering_Interests-2018-12.pdf
RBB_Partnering_Interests-2018-12.pdf
Respiratory_Partnering_Interests_2018-12.pdf
Technologies_Partnering_Interests-2018-12.pdf
Annual Press Conference 2024
Boehringer Ingelheim presents the 2023 results and an outlook for 2024 at the Annual Press Conference on April 16, 2024.
RE-LY-trial-publication-10-year-anniversary
Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers
Research Collaborations
Research Collaborations
Clinical Collaborations
Clinical Collaborations
Speak Up – Compliance Hotline
The Speak Up portal provides a safe environment to report potential violations and is open to any person worldwide. We take any reports of potential violations seriously.
International Postdocs realize their potential in Biberach
Three talented postdocs report on what they are working at Boehringer Ingelheim's research site in Biberach and what attracts them to the company.
Niha Agarwalla
My career challenge at Boehringer Ingelheim by Niha Agarwalla. Read it now!
Neovascular AMD (wet AMD)
Neovascular AMD (or wet AMD) is a severe form of advanced age-related macular degeneration that can lead to irreversible vision loss if untreated
Human Health Innovation
Human Health Innovation
Transforming Science Day
How our ‘patient first’ approach to innovation is aiming to accelerate breakthrough therapies that transform lives. Join our Transforming Science Day.
U.S. FDA approves first treatment for generalized pustular psoriasis flares in adults
Boehringer Ingelheim announces the U.S. FDA has approved the first treatment for generalized pustular psoriasis (GPP) flares in adults
Research Beyond Borders overview
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.